Hillstream BioPharma is a pre-clinical biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (“IMCD”) for treatment resistant cancers.
$5.00 - $6.00
January 12, 2022
FORDHAM FINANCIAL MANAGEMENT, INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Hillstream BioPharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277